Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 307.47M | 289.72M | 250.32M | 208.89M | 193.91M | 203.94M |
Gross Profit | 178.61M | 172.11M | 156.07M | 179.29M | 186.05M | 170.63M |
EBITDA | 61.20M | 69.33M | 57.80M | 81.16M | 91.00M | 78.91M |
Net Income | 47.06M | 53.00M | 43.38M | 61.44M | 69.01M | 59.49M |
Balance Sheet | ||||||
Total Assets | 6.96B | 5.81B | 5.71B | 5.67B | 5.50B | 4.90B |
Cash, Cash Equivalents and Short-Term Investments | 1.04B | 792.76M | 725.61M | 771.30M | 1.73B | 1.26B |
Total Debt | 628.73M | 544.95M | 529.94M | 309.51M | 255.94M | 246.77M |
Total Liabilities | 6.32B | 5.27B | 5.22B | 5.22B | 4.96B | 4.37B |
Stockholders Equity | 640.05M | 531.23M | 495.06M | 451.28M | 541.29M | 529.31M |
Cash Flow | ||||||
Free Cash Flow | 37.42M | 55.36M | 64.89M | 103.00M | 140.86M | 15.30M |
Operating Cash Flow | 44.21M | 60.93M | 67.51M | 105.18M | 142.72M | 18.23M |
Investing Cash Flow | 97.08M | 30.33M | -7.03M | -487.72M | -649.09M | -294.45M |
Financing Cash Flow | -98.59M | 23.90M | -36.10M | 237.34M | 581.23M | 346.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $663.64M | 15.16 | 6.26% | ― | 22.18% | 277.02% | |
75 Outperform | $698.97M | 10.89 | 11.13% | 2.72% | 7.98% | 10.16% | |
73 Outperform | $683.07M | 15.05 | 6.06% | 4.16% | 9.55% | 90.70% | |
71 Outperform | $675.92M | 10.38 | 15.04% | 3.19% | 5.59% | 7.03% | |
71 Outperform | $707.86M | 13.32 | 8.24% | 4.14% | 18.13% | 4.86% | |
67 Neutral | $16.85B | 11.65 | 9.71% | 3.90% | 11.61% | -9.60% | |
58 Neutral | $756.69M | ― | -1.83% | 1.99% | -5.43% | -186.90% |
On June 24, 2025, Camden National Corporation announced a quarterly dividend of $0.42 per share, resulting in an annualized dividend yield of 4.23% based on the June 23, 2025 closing stock price. The dividend is payable on July 31, 2025, to shareholders of record on July 15, 2025, reflecting the company’s commitment to providing value to its shareholders.
The most recent analyst rating on (CAC) stock is a Hold with a $42.00 price target. To see the full list of analyst forecasts on Camden National stock, see the CAC Stock Forecast page.
On May 20, 2025, Camden National held its Annual Meeting of Shareholders at the Hanley Center in Rockport, Maine, and virtually, where 83% of eligible votes were represented. During the meeting, shareholders elected twelve directors to the Board for a one-year term, approved an amendment to the 2022 Equity and Incentive Plan, endorsed executive compensation, and ratified the appointment of RSM US LLP as the independent auditor for 2025.
The most recent analyst rating on (CAC) stock is a Buy with a $53.00 price target. To see the full list of analyst forecasts on Camden National stock, see the CAC Stock Forecast page.